From the stable of Griffith University, Queensland, that launched OMI and Progen, comes Mediguard. Developing syringes, blood collecting, and IV devices and a small $5 million launch. The share price has dropped for the last 6 months but is now showing life with the latest announcement. With so few shares on issue, any news of success with the developments will be quickly transferred to the share price share. One to put on your watchlist.
They are also apparently front runners for the Australia design award..... so this would be a huge lift and certainly gain fresh interest in the share price :)
Add to My Watchlist
What is My Watchlist?